HomeCompareBOEUF vs MO

BOEUF vs MO: Dividend Comparison 2026

BOEUF yields 10.26% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $40.7K in total portfolio value· pulled ahead in Year 8
10 years
BOEUF
BOEUF
● Live price
10.26%
Share price
$19.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.4K
Annual income
$1,952.78
Full BOEUF calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — BOEUF vs MO

📍 MO pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBOEUFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BOEUF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BOEUF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BOEUF
Annual income on $10K today (after 15% tax)
$871.79/yr
After 10yr DRIP, annual income (after tax)
$1,659.86/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, MO beats the other by $23,975.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BOEUF + MO for your $10,000?

BOEUF: 50%MO: 50%
100% MO50/50100% BOEUF
Portfolio after 10yr
$59.8K
Annual income
$16,055.97/yr
Blended yield
26.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

BOEUF
No analyst data
Altman Z
45.0
Piotroski
6/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BOEUF buys
0
MO buys
0
No recent congressional trades found for BOEUF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBOEUFMO
Forward yield10.26%6.36%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$39.4K$80.1K
Annual income after 10y$1,952.78$30,159.17
Total dividends collected$14.9K$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: BOEUF vs MO ($10,000, DRIP)

YearBOEUF PortfolioBOEUF Income/yrMO PortfolioMO Income/yrGap
1$11,726$1,025.64$10,570$780.30+$1.2KBOEUF
2$13,670$1,123.95$11,381$1,032.90+$2.3KBOEUF
3$15,852$1,224.64$12,535$1,392.73+$3.3KBOEUF
4$18,289$1,327.17$14,193$1,920.91+$4.1KBOEUF
5$21,000$1,431.02$16,618$2,723.68+$4.4KBOEUF
6$24,006$1,535.66$20,263$3,993.80+$3.7KBOEUF
7$27,327$1,640.61$25,936$6,098.36+$1.4KBOEUF
8← crossover$30,985$1,745.40$35,166$9,775.01$4.2KMO
9$35,003$1,849.59$51,026$16,597.78$16.0KMO
10$39,406$1,952.78$80,113$30,159.17$40.7KMO

BOEUF vs MO: Complete Analysis 2026

BOEUFStock

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler. It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.

Full BOEUF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this BOEUF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BOEUF vs SCHDBOEUF vs JEPIBOEUF vs OBOEUF vs KOBOEUF vs MAINBOEUF vs PMBOEUF vs BTIBOEUF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.